<DOC>
	<DOCNO>NCT01078246</DOCNO>
	<brief_summary>The objective study monitor Health Outcomes Interest ( HOI ) participant human immunodeficiency virus-1 ( HIV-1 ) infection follow treatment Raltegravir .</brief_summary>
	<brief_title>Post-Licensure Safety Study ISENTRESSâ„¢ ( Raltegravir ) United States Managed Care Network ( MK-0518-268 )</brief_title>
	<detailed_description>Study participant contribute data one 3 cohort : 1 ) Historical Cohort : HIV-infected participant treat antiretroviral therapy course ordinary clinical practice clinic medical center Kaiser Permanente ( KP ) 1 January 2000 12 October 2007 ( date market authorization raltegravir USA ) , 2 ) Concurrent Cohort : HIV-infected participant treat new non-raltegravir antiretroviral therapy course ordinary clinical practice clinic medical center KP 12 October 2007 , 3 ) Raltegravir Cohort : HIV-infected participant treat raltegravir course ordinary clinical practice clinic medical center KP 12 October 2007 . Participants could contribute data one cohort , overlap follow-up time allow .</detailed_description>
	<mesh_term>Raltegravir Potassium</mesh_term>
	<criteria>Historical Cohort : HIVinfected participant treat antiretroviral therapy course ordinary clinical practice clinic medical center Kaiser Permanente ( KP ) 1 January 2000 12 October 2007 ( date market authorization raltegravir USA ) Raltegravir Cohort : HIVinfected participant treat raltegravir course ordinary clinical practice clinic medical center KP 12 October 2007 Concurrent Cohort : HIVinfected participant treat new nonraltegravir antiretroviral therapy course ordinary clinical practice clinic medical center KP 12 October 2007 All participant must least one year continuous membership KP prior date participant receive first dispense prescription study drug ( index date ) allow assessment medical treatment history Less 18 year age Do receive medication KP pharmacy system Do receive laboratory examination KP system Participating raltegravir phase III expand access program</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>HIV</keyword>
</DOC>